{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:35Z","timestamp":1787026295894,"version":"build-2736575974"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2018.00048","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T09:30:55Z","timestamp":1526549455000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field"],"prefix":"10.3389","volume":"5","author":[{"given":"Victor Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lopez-Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Palaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Mouhayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Marmagkiolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saamir A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Karimzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar A.","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11764-013-0267-9","article-title":"Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?","volume":"7","author":"Weaver","year":"2013","journal-title":"J Cancer Surviv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cjca.2016.04.008","article-title":"Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients","volume":"32","author":"Johnson","year":"2016","journal-title":"Can J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"III-27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","article-title":"Cancer drugs and the heart: importance and management","volume":"34","author":"Suter","year":"2013","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","article-title":"Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00059-011-3444-5","article-title":"Sorafenib-associated multivessel coronary artery vasospasm","volume":"36","author":"Naib","year":"2011","journal-title":"Herz"},{"key":"B14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1445-5994.2009.02144.x","article-title":"Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina","volume":"40","author":"Stewart","year":"2010","journal-title":"Intern Med J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-47","article-title":"A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity","volume":"15","author":"Polk","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/oxfordjournals.eurheartj.a062542","article-title":"Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer","volume":"9","author":"Stefenelli","year":"1988","journal-title":"Eur Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006278","article-title":"Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis of More Than 20\u00a0000 Patients","volume":"6","author":"Totzeck","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1179\/102453312X13336169156933","article-title":"Thrombosis in multiple myeloma (MM)","volume":"17","author":"Cesarman-Maus","year":"2012","journal-title":"Hematology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.2009.1137","article-title":"Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction","volume":"302","author":"Nanda","year":"2009","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/cncr.25597","article-title":"Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation","volume":"117","author":"Nguyen","year":"2011","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clgc.2014.06.016","article-title":"Role of androgen deprivation therapy in early salvage radiation among patients with prostate-specific antigen level of 0.5 or less","volume":"13","author":"Parekh","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/bju.12905","article-title":"Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer","volume":"116","author":"Ziehr","year":"2015","journal-title":"BJU Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis","volume":"103","author":"Amir","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clon.2013.06.012","article-title":"Understanding radiation-induced cardiovascular damage and strategies for intervention","volume":"25","author":"Stewart","year":"2013","journal-title":"Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1667\/RR1862.1","article-title":"Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients","volume":"174","author":"Stewart","year":"2010","journal-title":"Radiat Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.icrp.2012.06.031","article-title":"Mechanisms and dose-response relationships for radiation-induced cardiovascular disease","volume":"41","author":"Stewart","year":"2012","journal-title":"Ann ICRP"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2006.08.071","article-title":"Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?","volume":"67","author":"Schultz-Hector","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/annonc\/mdu130","article-title":"Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance\u2020","volume":"25","author":"Dani\u00ebls","year":"2014","journal-title":"Ann Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients\u00a0with\u00a0cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1200\/JCO.2001.19.4.1137","article-title":"Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia","volume":"19","author":"Elting","year":"2001","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jacc.2016.05.068","article-title":"Echocardiography and fluoroscopy-guided pericardiocentesis for cancer patients with cardiac tamponade and thrombocytopenia","volume":"68","author":"Iliescu","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1586\/14779072.3.5.941","article-title":"Targeting shear stress-induced platelet activation: is lesion-specific antiplatelet therapy a realistic clinical goal?","volume":"3","author":"Kroll","year":"2005","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"E202","DOI":"10.1002\/ccd.26379","article-title":"SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiolog\u0131a intervencionista)","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00062","article-title":"Viscoelastic methods of blood clotting assessment - a multidisciplinary review","volume":"2","author":"Benes","year":"2015","journal-title":"Front Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","article-title":"Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology","volume":"25","author":"Maisch","year":"2004","journal-title":"Eur Heart J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","article-title":"Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion","volume":"66","author":"El Haddad","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.echo.2008.12.013","article-title":"Echocardiography-guided interventions","volume":"22","author":"Silvestry","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"B44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0025-6196(11)65028-3","article-title":"Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy","volume":"75","author":"Tsang","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"B45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ahj.2012.06.011","article-title":"Impact of access site selection and operator expertise on radiation exposure; a controlled prospective study","volume":"164","author":"Lo","year":"2012","journal-title":"Am Heart J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ccd.27039","article-title":"Patient preference for radial versus femoral vascular access for elective coronary procedures: The PREVAS study","volume":"91","author":"Kok","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"B47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF03169153","article-title":"The radial artery: an alternative access site for diagnostic and interventional coronary procedures","volume":"174","author":"Mulvihill","year":"2005","journal-title":"Ir J Med Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-Elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-Elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00059-010-3339-x","article-title":"Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis","volume":"35","author":"Madhavan","year":"2010","journal-title":"Herz"},{"key":"B50","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ahj.2007.11.008","article-title":"Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction","volume":"155","author":"Prasad","year":"2008","journal-title":"Am Heart J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of Takotsubo Syndrome","volume":"135","author":"Pelliccia","year":"2017","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4330\/wjc.v6.i7.602","article-title":"Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment","volume":"6","author":"Komamura","year":"2014","journal-title":"World J Cardiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.2.226","article-title":"5-Fluorouracil-induced Tako-Tsubo-like syndrome","volume":"31","author":"Basselin","year":"2011","journal-title":"Pharmacotherapy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1200\/JCO.2012.42.4911","article-title":"Takotsubo syndrome in a patient treated with sunitinib for renal cancer","volume":"30","author":"Numico","year":"2012","journal-title":"J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jacc.2005.03.074","article-title":"Atherothrombosis and high-risk plaque: part I: evolving concepts","volume":"46","author":"Fuster","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jcin.2010.03.021","article-title":"Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry","volume":"3","author":"Berger","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jcin.2017.06.001","article-title":"Risk of early adverse events after clopidogrel discontinuation in patients undergoing short-term dual\u00a0antiplatelet\u00a0therapy: an individual participant data analysis","volume":"10","author":"Piccolo","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"B58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ahj.2017.08.015","article-title":"\"Bringing on the light\" in a complex clinical scenario: optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry)","volume":"194","author":"Iliescu","year":"2017","journal-title":"Am\u00a0Heart J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1161\/01.CIR.89.3.1013","article-title":"Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography","volume":"89","author":"de Bruyne","year":"1994","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","article-title":"Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial","volume":"36","author":"Zimmermann","year":"2015","journal-title":"Eur Heart J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1161\/CIR.0b013e31823ba622","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with\u00a0stable ischemic heart\u00a0disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jacc.2011.11.003","article-title":"Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study","volume":"59","author":"Sen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.4244\/EIJV8I10A179","article-title":"Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation","volume":"8","author":"Petraco","year":"2013","journal-title":"EuroIntervention"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jacc.2017.07.770","article-title":"The evolving future of instantaneous\u00a0wave-free ratio and fractional flow\u00a0reserve","volume":"70","author":"G\u00f6tberg","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"Nishimura","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/S0140-6736(16)30073-3","article-title":"Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis","volume":"387","author":"Thourani","year":"2016","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.athoracsur.2011.06.060","article-title":"The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals","volume":"92","author":"Bavaria","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1308\/003588412X13171221591817","article-title":"Unoperated severe aortic stenosis: decision making in an adult UK-based population","volume":"94","author":"Badran","year":"2012","journal-title":"Ann R Coll Surg Engl"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ahj.2011.03.013","article-title":"Management and outcomes of severe aortic stenosis in cancer patients","volume":"161","author":"Yusuf","year":"2011","journal-title":"Am Heart J"},{"key":"B75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2478\/raon-2013-0078","article-title":"Balloon aortic valvuloplasty (BAV) as a bridge to aortic valve replacement in cancer patients who require urgent non-cardiac surgery","volume":"48","author":"Kogoj","year":"2014","journal-title":"Radiol Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jcin.2015.03.005","article-title":"Thrombus formation following transcatheter aortic valve replacement","volume":"8","author":"de Marchena","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jacc.2016.08.010","article-title":"Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications","volume":"68","author":"Hansson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00252982","article-title":"Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy","volume":"19","author":"Samuels","year":"1987","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00048\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T09:30:56Z","timestamp":1526549456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00048\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":79,"alternative-id":["10.3389\/fcvm.2018.00048"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2018.00048","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"article-number":"48"}}